Dietary Supplements Commonly Used by Cancer Survivors: Are There Any Benefits? (Q38622264)

4 September 2017

title

Dietary Supplements Commonly Used by Cancer Survivors: Are There Any Benefits? (English)

1 reference

4 September 2017

Mary J Marian

1

1 reference

4 September 2017

publication date

1 August 2017

1 reference

Nutrition in Clinical Practice

4 September 2017

published in

1 reference

4 September 2017

page(s)

884533617721687

1 reference

Supplement use during an intergroup clinical trial for breast cancer (S0221).

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Trends in Dietary Supplement Use Among US Adults From 1999-2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Is voluntary vitamin and mineral supplementation associated with better outcome in non-small cell lung cancer patients? Results from the Mayo Clinic lung cancer cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

A nutrient approach to prostate cancer prevention: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Antioxidant intake and pancreatic cancer risk: the Vitamins and Lifestyle (VITAL) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

A prospective study of vitamin and mineral supplement use and the risk of upper gastrointestinal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Dietary intake, supplement use, and survival among women diagnosed with early-stage breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Multivitamin use and colon cancer mortality in the Cancer Prevention Study II cohort (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Vitamin supplement use during breast cancer treatment and survival: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Multivitamin and mineral use and breast cancer mortality in older women with invasive breast cancer in the women's health initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

The association between postdiagnosis dietary supplement use and total mortality differs by diet quality among older female cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Dietary patterns and breast cancer recurrence and survival among women with early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Mechanisms of the Anti-Cancer and Anti-Inflammatory Actions of Vitamin D

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Vitamin D and Colorectal, Breast, and Prostate Cancers: A Review of the Epidemiological Evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

WCRF-AICR continuous update project: Systematic literature review of prospective studies on circulating 25-hydroxyvitamin D and kidney cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Plasma vitamin D concentration influences survival outcome after a diagnosis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Vitamin D and the epidemiology of upper gastrointestinal cancers: a critical analysis of the current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Effect of Vitamin D and Calcium Supplementation on Cancer Incidence in Older Women: A Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Vitamin D is associated with improved survival in early-stage non-small cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Circulating 25-hydroxyvitamin D and risk of lung cancer: a dose-response meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Vitamin D and lung cancer risk: a comprehensive review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Serum 25-Hydroxyvitamin D and Risk of Lung Cancer in Male Smokers: A Nested Case-Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Vitamin D intake and lung cancer risk in the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Association Between Vitamin D and Risk of Colorectal Cancer: A Systematic Review of Prospective Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Could vitamin D sufficiency improve the survival of colorectal cancer patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Prognostic role of 25-hydroxyvitamin D in patients with liver metastases from colorectal cancer treated with radiofrequency ablation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Calcium plus vitamin D supplementation and the risk of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Higher blood 25(OH)D level may reduce the breast cancer risk: evidence from a Chinese population based case-control study and meta-analysis of the observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Vitamin D and breast cancer recurrence in the Women's Healthy Eating and Living (WHEL) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Calcium plus vitamin D supplementation and the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Improved clinical outcomes associated with vitamin D supplementation during adjuvant chemotherapy in patients with HER2 nonmetastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Positive association between circulating 25-hydroxyvitamin D levels and prostate cancer risk: new findings from an updated meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Vitamin D3Supplementation at 4000 International Units Per Day for One Year Results in a Decrease of Positive Cores at Repeat Biopsy in Subjects with Low-Risk Prostate Cancer under Active Surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Association between serum 25(OH)D and death from prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Vitamin D and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Vitamin D and pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Impact of vitamin D deficiency on the clinical presentation and prognosis of patients with newly diagnosed multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Validation of a vitamin D replacement strategy in vitamin D-insufficient patients with lymphoma or chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Serum 25-Hydroxyvitamin D Levels and the Risk of Dysplasia and Esophageal Adenocarcinoma in Patients with Barrett's Esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Longitudinal, observational study on associations between postoperative nutritional vitamin D supplementation and clinical outcomes in esophageal cancer patients undergoing esophagectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Circulating 25-Hydroxyvitamin D3 in Relation to Renal Cell Carcinoma Incidence and Survival in the EPIC Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Vitamin D Deficiency and Increased Risk of Bladder Carcinoma: A Meta-Analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Vitamin D intake, serum Vitamin D levels, and risk of gastric cancer: A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Meta-analysis: Circulating vitamin D and ovarian cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

A systematic literature review of vitamin D and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Animal models in carotenoids research and lung cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Antioxidant Intake and Antitumor Therapy: Toward Nutritional Recommendations for Optimal Results

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Efficacy and Interaction of Antioxidant Supplements as Adjuvant Therapy in Cancer Treatment: A Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

The promise and perils of antioxidants for cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Modulation of oxidative stress as an anticancer strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: a double-blind randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Chemotherapy alone vs. chemotherapy plus high dose multiple antioxidants in patients with advanced non small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Chemistry and biology of vitamin E

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Source-specific effects of micronutrients in lung cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Dietary, supplement, and adipose tissue tocopherol levels in relation to prostate cancer aggressiveness among African and European Americans: The North Carolina-Louisiana Prostate Cancer Project (PCaP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Vitamin E and C supplementation and risk of cancer in men: posttrial follow-up in the Physicians' Health Study II randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Plasma tocopherols and risk of prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Supplemental ascorbate in the supportive treatment of cancer: Reevaluation of prolongation of survival times in terminal human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Ascorbic acid does not reduce the anticancer effect of radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Pharmacological concentrations of ascorbate radiosensitize glioblastoma multiforme primary cells by increasing oxidative DNA damage and inhibiting G2/M arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Ascorbic acid inhibits antitumor activity of bortezomib in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Mechanisms of cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Supportive Management of Mucositis and Metabolic Derangements in Head and Neck Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Comparative effects of different enteral feeding methods in head and neck cancer patients receiving radiotherapy or chemoradiotherapy: a network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Oral Glutamine in Preventing Treatment-Related Mucositis in Adult Patients With Cancer: A Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Efficacy of glutamine in the prevention of acute radiation enteritis: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Therapeutic applications of herbal medicines for cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Astragalus polysaccharide injection integrated with vinorelbine and cisplatin for patients with advanced non-small cell lung cancer: effects on quality of life and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Astragalus-containing Traditional Chinese Medicine, with and without prescription based on syndrome differentiation, combined with chemotherapy for advanced non-small-cell lung cancer: a systemic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Oxaliplatin-based chemotherapy combined with traditional medicines for neutropenia in colorectal cancer: A meta-analysis of the contributions of specific plants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Melatonin: action as antioxidant and potential applications in human disease and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Melatonin-immune system relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Melatonin as adjuvant cancer care with and without chemotherapy: a systematic review and meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Effects of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: a double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Effect of Oral Silymarin Administration on Prevention of Radiotherapy Induced Mucositis: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Phase II trial of curcumin in patients with advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Evaluation of the effect of curcumin capsules on glyburide therapy in patients with type-2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Structural insights into Resveratrol's antagonist and partial agonist actions on estrogen receptor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Antiemetic effect of ginger in gynecologic oncology patients receiving cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Effect of ginger on acute and delayed chemotherapy-induced nausea and vomiting: a pilot, randomized, open-label clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Can ginger ameliorate chemotherapy-induced nausea? Protocol of a randomized double blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Pharmacology of ginsenosides: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

A clinical trial of amygdalin (Laetrile) in the treatment of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Laetrile treatment for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

The methodological quality of randomized controlled trials of homeopathy, herbal medicines and acupuncture

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

Circulating 25-Hydroxyvitamin D Levels Predict Survival in Early-Stage Non–Small-Cell Lung Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0884533617721687

21 January 2018

Identifiers

DOI

10.1177/0884533617721687

1 reference

4 September 2017

1 reference